CLINICAL_TRIALS trial_result · 2011-02-21

Clinical Trial Update: The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV) [Phase 4]

This article reports results from the DURABLE Phase 4 trial assessing the durability of starter insulin regimens in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2011-02-21